IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:75-82.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0344

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Missotten, G. S.
Right arrow Articles by De Wolff-Rouendaal, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Missotten, G. S.
Right arrow Articles by De Wolff-Rouendaal, D.

Conjunctival Melanoma in The Netherlands: A Nationwide Study

Guy S. Missotten, Sander Keijser, Rob J. W. De Keizer, and Didi De Wolff-Rouendaal

From the Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

PURPOSE. To evaluate risk factors for local recurrence, regional and distant metastases, and mortality associated with conjunctival melanoma.

METHODS This was a retrospective study of 194 patients with histologically confirmed conjunctival melanoma diagnosed between 1950 and 2002 in the Netherlands. Data were collected from all university centers and many nontertiary hospitals, using the National Pathology and the Leiden Oncologic Registration Systems. Based on the number of incidences, this study included 70% of the conjunctival melanomas in The Netherlands. Clinical and histopathological data for conjunctival tumors were reviewed and compared with data reported in the literature. Risk factors for local, regional, and distant metastases and survival were analyzed using the Kaplan-Meier and Cox regression analyses.

RESULTS. Of 194 patients with conjunctival melanoma, 112 had a local recurrence (median, 1; range, 1–9) during follow-up (median, 6.8 years; range, 0.1–51.5). Location was the most important risk factor for development of local recurrence, and significantly more occurred with nonepibulbar (log rank, P = 0.044) tumors. Significantly fewer local recurrences occurred with tumors initially treated with excision and adjuvant brachytherapy rather than with excision only (log rank, P = 0.008) or with excision and cryotherapy (log rank, P < 0.038). Forty-one (21%) patients had regional lymph node metastases, mostly to the parotid or preauricular lymph nodes (n = 26; 13%). Risk factors for regional metastases were tumor thickness (log rank, P < 0.001) and tumor diameter (log rank, P = 0.010). Forty-nine (25%) patients (mean, 4.37 years) had development of distant metastases, mainly in the lung, liver, skin, and brain. Tumor-related survival was 86.3% (95% confidence interval [CI], 81.0–91.6) at 5 years, 72% (95% CI, 79.7–64.4) at 10 years, and 67% (95% CI, 58.9–76.1) at 15 years. The main mortality risk factors were nonepibulbar location (log rank, P < 0.0001) and tumor thickness (log rank, P = 0.0004).

CONCLUSIONS. Nonepibulbar tumors more often recur locally and are associated with a shorter survival independent of other risk factors. Tumor thickness is also an important predictor of regional and distant metastases, as well as survival. A prospective study is needed to compare the effect of excision with radiotherapy and excision with cryotherapy on the number of local recurrences, exenteration rate, and survival.





This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
S. Keijser, W. Maat, G. S Missotten, and R. J W de Keizer
A new cell line from a recurrent conjunctival melanoma
Br. J. Ophthalmol., November 1, 2007; 91(11): 1566 - 1567.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S Keijser, G S Missotten, J M Bonfrer, D de Wolff-Rouendaal, M J Jager, and R J W de Keizer
Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions
Br. J. Ophthalmol., February 1, 2006; 90(2): 213 - 217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology